Sms Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ZOLMITRIPTAN, with a corresponding US DMF Number 20110.
Remarkably, this DMF maintains an Active status since its submission on January 04, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 04, 2015, and payment made on April 21, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II